These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 14221802

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. THE CORRELATION BETWEEN TRANSPLANTED MOUSE AND HUMAN ACUTE LEUKEMIAS.
    BURCHENAL JH, OETTGEN HF, LYMAN M, PURPLE J.
    Acta Unio Int Contra Cancrum; 1964; 20():256-9. PubMed ID: 14151900
    [No Abstract] [Full Text] [Related]

  • 3. DRUG SYNERGISM IN ANTINEOPLASTIC CHEMOTHERAPY.
    VENDITTI JM, GOLDIN A.
    Adv Chemother; 1964; 13():397-498. PubMed ID: 14195200
    [No Abstract] [Full Text] [Related]

  • 4. THE EFFECT OF A PHTHALANILIDE DERIVATIVE ON LIPIDE METABOLISM IN L1210 LEUKEMIA CELLS.
    GELLHORN A, WAGNER M, RECHLER M, KOREN Z, BENJAMIN W.
    Cancer Res; 1964 Apr; 24():400-8. PubMed ID: 14147813
    [No Abstract] [Full Text] [Related]

  • 5. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ.
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. THERAPEUTIC AND IMMUNOLOGICAL RESPONSE OF MICE WITH MENINGEAL LEUKEMIA (L1210) TO CHALLENGE WITH AN ANTIFOLIC-RESISTANT VARIANT.
    CHIRIGOS MA, THOMAS LB, HUMPHREYS SR, GLYNN JP, GOLDIN A.
    Cancer Res; 1964 Apr; 24():409-15. PubMed ID: 14147814
    [No Abstract] [Full Text] [Related]

  • 9. Combined interferon--antimetabolite therapy of murine L1210 leukemia.
    Slater LM, Wetzel MW, Cesario T.
    Cancer; 1981 Jul 01; 48(1):5-9. PubMed ID: 6165457
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. EVALUATION OF ANTILEUKEMIC AGENTS EMPLOYING ADVANCED LEUKEMIA L1210 IN MICE. VII.
    VENDIITI JM, SHELDON DR, GOLDIN A.
    Cancer Res; 1964 Jan 01; 24():145-96. PubMed ID: 14106543
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.
    Warzocha K, Robak T.
    Acta Haematol Pol; 1992 Jan 01; 23(1):55-62. PubMed ID: 1615753
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CATALASE ACTIVITY IN MOUSE LEUKEMIA L1210.
    LOTTSFELDT FI, PEHOUSHEK C, KRIVIT W.
    Cancer Res; 1965 Feb 01; 25():370-3. PubMed ID: 14264061
    [No Abstract] [Full Text] [Related]

  • 18. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J, Robak T, Warzocha K, Grieb P.
    Arch Immunol Ther Exp (Warsz); 1994 Feb 01; 42(1):39-42. PubMed ID: 7503633
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Investigation of the activity of cytoxan against leukemia L1210 in mice.
    VENDITTI JM, HUMPHREYS SR, GOLDIN A.
    Cancer Res; 1959 Oct 01; 19():986-95. PubMed ID: 13841661
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.